Science v. COVID-19: Promising COVID-19 Treatments Explained
COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines,...
COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines,...
Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success...
Despite COVID -19, 2020 was a remarkable year for venture fundraising and investment in healthcare. Strong exits propelled a fourth straight record year in venture...
Join UConn Technology Commercialization Services ('TCS') for a Fireside chat discussing: The key characteristics of geniuses, teams and creativity, genius as a binary scenario, the...
The beginning of 2021 is already getting off to a busy start. With the end of one presidential administration, the beginning of a new one,...
Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment...
For many business leaders, the past year has been filled with obstacles and challenges that have required full-time, relentless attention to every detail of the...
This webinar is designed for a quick overview about some ways to address the 3 important facets of any organization: Sales, Human Capital, and Strategy....
Gene therapy using adeno-associated virus (AAV) as a vector has emerged as a novel therapeutic modality that has the potential to lead to substantial disease...
The term digital health has evolved over the years and includes various type of technologies, including telemedicine, digital therapeutics, mobile health, wearables, remote monitoring, etc....